EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Osteosarcopenia, Osteoporosis, and Sarcopenia in Liver Cirrhosis: Prevalence, Predictors, and Prognostic Significance of IGF-1 Deficiency

Tanja Glamočanin iD, Tanja Veriš Smiljić iD, Marina Vukčević iD, Željka Savić iD, Renata Tamburić, Goran Bokan iD, Milan Kulić, Nenad Lalović, Nemanja Lazendić iD, Bojan Joksimović iD, Dario Djukić iD, Alma Prtina und 1 weitere

Journal of Clinical Medicine · 26.03.2026 · 15 (7) · 2534

DOI: 10.3390/jcm15072534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.03.2026. Verfasst von Tanja Glamočanin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Clinic, Department of Gastroenterology and Hepatology, University Clinical Center of the Republic of Srpska, 78000 Banja Luka, Bosn…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Sarcopenia (SP) and osteoporosis (OP) are common yet underrecognized complications of liver cirrhosis, contributing to increased morbidity and mortality. Their coexistence, termed osteosarcopenia (OS), represents a compounded musculoskeletal impairment. Insulin-like growth factor 1 (IGF-1), synthesized in the liver, has been implicated in muscle and bone metabolism. This study aimed to assess the prevalence and association of laboratory and clinical parameters with SP, OP, and OS in cirrhotic patients, with a focus on IGF-1 deficiency and their impact on mortality.

Methods

This cross-sectional study included 100 cirrhotic patients at a tertiary center. Sarcopenia was diagnosed using CT-derived L3 skeletal muscle index and osteoporosis via the DEXA scan. IGF-1 levels and metabolic parameters were measured. Multivariate logistic regression identified laboratory and clinical factors associated with musculoskeletal complications. However, due to the cross-sectional design, causal relationships could not be inferred.

Results

SP, OP, and OS were present in 41%, 22%, and 11% of patients, respectively. IGF-1 levels were significantly lower in patients with SP, OP, and OS (p < 0.05) and were independently associated with increased risk of SP (OR = 1.797, p = 0.006), OP (OR = 1.873, p = 0.045), and OS (OR = 2.326, p = 0.003). Mortality rates were significantly higher among patients with OS (72.7%), OP (77.3%), and SP (56.1%). OS conferred the highest adjusted mortality risk (OR = 2.739, p = 0.009), followed by SP (OR = 2.278, p = 0.015) and OP (OR = 1.958, p = 0.036).

Conclusions

Musculoskeletal complications are highly prevalent and predictive of mortality in cirrhosis. IGF-1 deficiency is a strong independent biomarker for SP, OP, and OS. Routine screening and early intervention targeting IGF-1 pathways and nutrition may improve outcomes in this population.

Schlagwörter

Stichwörter der Autor:innen

IGF-1liver cirrhosismortalityosteoporosisosteosarcopeniasarcopenia

Autor:innen und Institutionen

  • Internal Medicine Clinic, Department of Gastroenterology and Hepatology, University Clinical Center of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.
  • Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
  • Clinic of Radiology, University Clinical Centre of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.
  • Internal Medicine Clinic, Department of Rheumatology, University Clinical Center of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.
  • Clinic for Gastroenterology and Hepatology, Clinical Centre of Novi Sad, 21000 Novi Sad, Serbia.
  • Faculty of Medicine Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.

ORCID-Profile: Tanja Glamočanin, Tanja Veriš Smiljić, Marina Vukčević, Željka Savić, Goran Bokan, Nemanja Lazendić, Bojan Joksimović, Dario Djukić

Zitieren

APA

Glamočanin, T., Smiljić, T. V., Vukčević, M., Savić, Ž., Tamburić, R., Bokan, G., Kulić, M., Lalović, N., Lazendić, N., Joksimović, B., Djukić, D., Prtina, A., & Nogo-Živanović, D. (2026). Osteosarcopenia, Osteoporosis, and Sarcopenia in Liver Cirrhosis: Prevalence, Predictors, and Prognostic Significance of IGF-1 Deficiency. Journal of Clinical Medicine, 15(7), 2534. https://doi.org/10.3390/jcm15072534

Vancouver

Glamočanin T, Smiljić TV, Vukčević M, Savić Ž, Tamburić R, Bokan G, et al. Osteosarcopenia, Osteoporosis, and Sarcopenia in Liver Cirrhosis: Prevalence, Predictors, and Prognostic Significance of IGF-1 Deficiency. Journal of Clinical Medicine. 2026;15(7):2534. doi:10.3390/jcm15072534

BibTeX
@article{Glamoanin2026,
  author = {Glamočanin, Tanja and Smiljić, Tanja Veriš and Vukčević, Marina and Savić, Željka and Tamburić, Renata and Bokan, Goran and Kulić, Milan and Lalović, Nenad and Lazendić, Nemanja and Joksimović, Bojan and Djukić, Dario and Prtina, Alma and Nogo-Živanović, Dajana},
  title = {Osteosarcopenia, Osteoporosis, and Sarcopenia in Liver Cirrhosis: Prevalence, Predictors, and Prognostic Significance of IGF-1 Deficiency},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {2534},
  doi = {10.3390/jcm15072534}
}
Kostenlos starten →